Hybridization of a 99tcm-labelled oligodeoxynucleotide to capl rna

Nuclear Medicine Communications

Volumn 19, Issue 8, 1998, Pages 803-812

  Hjelstuen, O K ^a   TONnesen H H ^a   MOLandsmo G M ^b   Bremmer, P O ^c   Verbruggen, A M ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Isopharma AS   (Norway)

^d University of Leuveu   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

(BENZOYLTHIO)ACETYLTRIGLYCINE; CALCIUM BINDING PROTEIN; CHELATING AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GLYCINE; MESSENGER RNA; OLIGODEOXYRIBONUCLEOTIDE; PHOSPHORUS; PROTEIN S 100; S-BENZOYLMERCAPTOACETYLTRIGLYCINE; S100A4 PROTEIN, HUMAN; TECHNETIUM; COMPLEMENTARY RNA; OLIGODEOXYNUCLEOTIDE; TECHNETIUM 99M;

ARTICLE; FEMALE; GENETICS; HUMAN; NEOPLASM; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDE SEQUENCE; SCINTISCANNING; BREAST CANCER; CANCER DIAGNOSIS; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; GENE TECHNOLOGY; ISOTOPE LABELING; METASTASIS; OSTEOSARCOMA;

BASE SEQUENCE; CALCIUM-BINDING PROTEINS; CHELATING AGENTS; FEMALE; GLYCINE; HUMANS; NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHORUS RADIOISOTOPES; RNA, MESSENGER; S100 PROTEINS; TECHNETIUM;

EID: 0031596036     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199808000-00012     Document Type: Article

References (19)

1. Wagner RW. Gene inhibition using antisense oligodeoxynucleotides. Nature 1994; 372: 333-335.
2. Stein CA, Cheng YC. Antisense oligonucleotides as therapeutic agents: Is the bullet really magical? Science 1993; 260: 1004-1012.
3. Matteucci MD, Wagner RD. In pursuit of antisense. Nature 1996; 384: 20-22.
4. Ebralidze A, Tulchinsky E, Grigorian M et at. Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2+-binding protein family. Genes Rev 1989; 3: 1086-1093.
5. Engelkamp D, Schafer BW, Mattei MG, Erne P, Heizmann CW. Six S100 genes are clustered on human chromosome lq21: Identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E. Proc Natl Acad Sci USA 1993; 90: 6547-6551.
6. Davies BR, Davies MP, Gibbs FE, Barraclough R, Rudland PS. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium binding protein, but not with the oncogene EJ-ras-1. Oncogene 1993; 8: 999-1008.
7. Pedrocchi M, Schafer BW, Mueller H, Eppenberger U, Heizmann CW. Expression of Ca2+-binding proteins of the SI00 family in malignant human breast-cancer cell lines and biopsy samples, Int J Cancer 1994; 57: 684-690.
8. Maslandsmo GM, Hovig E, Skrede M Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mtsl) ribozyme. Cancer Res 1996; 56: 5490-5498.
9. Dewanjee MK, Ghafouripour AK, Kapadvanjawala M et al. Noninvasive imaging of c-myc oncogene messenger RNA with indium-lll-antisense probes in a mammary tumor-bearing mouse model. J Nucl Med 1994; 35: 1054-1063.
10. Hnatowich DJ, Winnard Jr P, Virzi F. Technetium-99m labeling of DNA oligonucleotides. J Nucl Med 1995; 36: 2306-2314.
11. Wagner RW, Matteucci MD, Lewis JG, Guiterrez AJ, Moulds C, Froehler BC. Antisense gene inhibition by oligonucleotides containing C-5 propvne pyrimidines. Science 1993; 260: 1510-1513.
12. Uhlmann E, Pevman A. Antisense oligonucleotides: A new therapeutic principle. Chem Rev 1990; 90: 544-584.
13. Shaw JP, Kent K, Bird J, Fishback J, Froehler B. Modified deoxvoligonucleotides stable to exonuclease degradation in serum. Nucleic Acids Res 1991; 19: 747-750.
14. Schneider RF, Subramanian G, Feld TA NV’-bis(S-benzoylmercaptoacetamido)ethylenediamine and propvle-nediamine ligands as renal function imaging agents. I. Alternate synthetic methods. J Nucl Med 1984; 25: 223-229.
15. Hjelstuen OK, Tonnesen HH, Bremer PO, Verbruggen AM. 3’-M4mTc-labeling and biodistribution of a CAPL antisense oligodeoxvnucleotide. Nucl Med Biol (in press).
16. Berkner KL, Folk WR. Polynucleotide kinase exchange reaction: Quantitative assay for restriction endonucleasegenerated 5’-phosphoryl termini in DNAs. J Biol Clwm 1977; 252: 3176-3184.
17. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
18. Hnatowich DJ. Labelling oligonucleotides with imagable radionuclides. In: Mather S, ed. Current directions in radiopharmaceutical research and development, Vol. 1. London: Cleuver, 1996: 157-168.
19. Crooke RM. In vitro toxicology and pharmacokinetics of antisense oligonucleotides. Anti-Cancer Drug Design 1991; 6: 609-646.